Research programme: cancer therapeutics - Cancer Research Technology/The Institute of Cancer Research/Nuevolution
Latest Information Update: 23 Sep 2015
At a glance
- Originator Cancer Research Technology; Nuevolution; The Institute of Cancer Research
- Developer Cancer Research Technology; Nuevolution
- Class Small molecules
- Mechanism of Action Protein modulators
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Research Cancer